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Abstract
Urinary incontinence is a complex and serious condition that can affect all age groups 
around the world. It is not only a serious medical condition but also an undeniable psy‐
chosocial problem creating embarrassment and negative self‐perception, and it has a 
severe impact on a patient's quality of life. Today, there are wide different treatment 
options in urinary incontinence from surgery to conservative modalities. Among these, 
conservative management approaches are recommended as the first‐line treatment to 
manage with urinary incontinence. The choice of the most suitable option to treat for 
urinary incontinence differs according to the underlying pathophysiological mechanism 
defining subtypes of urinary incontinence and severity of symptoms. In this chapter, we 
addressed the different components of physiotherapy management of urinary inconti‐
nence, including pelvic floor muscle training, electrical stimulation, biofeedback, vagi‐
nal cones, mechanical devices and magnetic stimulation. We concluded that the optimal 
physiotherapy care should be individualised to ensure applicability the clinic setting for 
each patient.
Keywords: urinary incontinence, pelvic floor muscle training, physiotherapy, 
biofeedback, women
1. Introduction
Urinary incontinence (UI) is defined by the International Continence Society as any invol‐
untary leakage of urine [1]. It is one of the most common health problems seen in women of 
nearly all ages [2] and affects up to two‐thirds of all women [3]. It is more frequent in women, 
and it is particularly common among those in residential care [4].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Female urinary incontinence is a complex situation [5]. It has been stated that UI might be 
indicative of a symptom, sign or condition. The symptom may indicate a state of loss of 
 urinary control; the sign is the objective demonstration of urine leak, and the condition is the 
urodynamic demonstration and characterisation of urine loss [6].
UI should not be classified only as a serious medical condition leading to lower urinary tract 
infections and perineal rash but also as an undeniable psychosocial problem (Figure 1), creat‐
ing embarrassment and negative self‐perception [7]. This in turn affects a wide aspect of daily 
life, including the social, psychological, occupational, domestic, physical and sexual activities 
of women [2]. UI has been found to result in reduced social interactions and physical activi‐
ties [8] and is commonly associated with poor self‐rated health [9], impaired psychological 
well‐being, sexual relationships, decreased quality of life (QoL) [10] and increased depressive 
symptoms [11]. It may restrict employment and educational or leisure opportunities leading 
to embarrassment and exclusion [12].
There is a wide range of literature on the prevalences of UI [13, 14]. This can be explained by 
the differences in the definition of UI, in epidemiologic methodology, and in the demographic 
characteristics among the studies [13–15]. About 25% of young women, 44–57% of middle‐
aged and postmenopausal women, and about 75% of older women experience some involun‐
tary urine loss [16]. In the 5th International Consultation on Incontinence (2012), it is stated 
that the prevalence of UI in the population varies between 30% and 60% in middle‐aged and 
older women and it increases with age. In addition, the prevalence of daily UI changes from 
5 to 15%, and it rises over 15% in women aged above 70 years [14]. Although these ranges of 
prevalence of UI are usually underestimated in the clinical setting, since patients often fail to 
bring the condition to the attention of their physicians. It is estimated that only one in four 
symptomatic women seeks help for this problem [17].
Figure 1. Psycho‐social problems seen in urinary incontinence.
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UI affects not only the sufferers but also their family, friends and the general public, due to its 
associated medical costs and social stigma [18]. UI is generally not related directly to survival 
but affects the QoL of the patients, causes mental distress and reduces day‐to‐day activities. 
When the treatment for UI results in the alleviation or cure of the condition, the distress can 
be eliminated and return to a normal life is possible [19]. In general, the choice of treatment 
primarily depends on the balance between efficacy and the associated complications. A variety 
of effective conservative treatment modalities are available to manage symptoms of UI [20].
There are several risk factors associated with UI in women (Figure 2). These include age, 
obesity, race/ethnicity, childbirth, oral hormonal therapy, prior hysterectomy, cognitive 
impairment, mobility impairment, diabetes [21], history of pelvic and perineal surgery [5] 
pregnancy, pelvic floor trauma after vaginal delivery and menopause [22]. UI may also occur 
as a result of a number of abnormalities of function of the lower urinary tract, or as a result of 
other illnesses [23], use of diuretics, sedentary lifestyles, caffeinated and carbonated drinks, 
severe and/or chronic cough resulting from, for example, chronic bronchitis or smoking, blad‐
der stones, short urethra and hypoestrogenemia. These conditions may lead to urinary leak‐
age under different situations [24].
The different types of incontinences are distinguished by their baseline mechanisms [16]. 
There are three major subtypes of UI: stress urinary incontinence (SUI), urge urinary incon‐
tinence (UUI) (urgent need to void) and mixed urinary incontinence (MUI) [25]. SUI is char‐
acterised by involuntary loss of urine without any previous feeling of a need to void, which 
occurs while under a physical stress like cough, lifting something heavy or any other physical 
activities [5]. UUI is characterised by an involuntary leakage accompanied by or immediately 
preceded by urgency that is difficult to defer followed by an irresistible need to void [25], 
resulting in uncontrollable leakage of urine [5]. MUI refers to the involuntary leakage associ‐
ated with variable proportions of urgency and also with exertion, effort, sneezing or coughing 
Figure 2. Risk factors for urinary incontinence.
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[25–27]. These definitions reflect the consensus definitions developed by the International 
Urogynecological Association and International Continence Society [27]. There are also less 
common categories of UI. These include total incontinence which is associated with urinary 
tract fistula or ectopic ureter, functional incontinence, which is associated with psychiatric or 
mobility disorders, overflow incontinence, post‐micturition dribble, radiotherapy and climac‐
turia [28], nocturnal enuresis, continuous UI and UI due to idiopathic or neurogenic detrussor 
[29]. Different types of incontinence, their definitions and possible causes are given in Table 1 
[14, 30].
There exists a wide range of treatment options to treat UI from surgical interventions to 
conservative modalities. Current guidelines recommend conservative management that is 
defined as interventions that do not involve treatment with drugs or surgery targeted to the 
type of incontinence [23, 31], as the first‐line therapy in UI [13, 31, 32]. Therefore, there is an 
option for conservative management, and physiotherapy, particularly for women who have 
not completed their childbearing and for those with mild symptoms [33]. Physical therapy 
modalities have been in use for several decades to treat UI and other lower urinary tract 
symptoms. They have been adopted by several disciplines and are implemented in many 
different ways [34].
Types of urinary incontinence
Types Definitions Pathophysiology and causes
Stress urinary incontinence Loss of urine during physical movements 
(coughing, sneezing, jumping, lifting, 
exercising)
Weakness of pelvic floor muscles or 
urethral sphincters, post‐urologic 
surgery
Urge urinary incontinence Leakage of urine at unexpected times 
accompanied by, or immediately preceded 
by a strong desire to void
Detrusor overactivity (uninhibited 
bladder contractions), neurologic 
disorders
Mixed urinary incontinence Involuntary leakage associated with 
symptoms of urgency; loss of urine with 
exertion, effort, sneezing or coughing
Mixed etiology of stress and urge 
urinary incontinence
Overflow incontinence Unexpected leakage of small amounts of 
urine because of a full bladder
Anatomic obstructions of urethra, 
a contractile bladder, neurogenic 
problems
Functional incontinence Urinary accidents associated with the 
inability to toilet because of impairment of 
cognitive and or physical functioning
Severe cognitive, mobility or 
psychological impairments
Nocturnal enuresis The complaint of loss of urine during sleep Genetics, nocturnal polyuria, idiopatic
Continuous incontinence The complaint of continuous leakage Diabetes, multiple sclerosis, blockage 
of urinary tracts
Total incontinence The continuous and total loss of urinary 
control
Neurogenic or cognitive problems, 
vesicovaginal fistula, spinal cord 
injuries
Table 1. Types of urinary incontinence, their definitions and pathophysiologic mechanisms with possible causes.
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The main purpose of the conservative management is to strengthen the pelvic floor and mod‐
ulate behaviours that influence bladder function, whereas pharmacological therapies targets 
innervating the bladder and sphincter [16, 22]. The aim of conservative rehabilitation therapy 
is to stabilise the urethra by increasing pelvic floor muscle (PFM) strength (force‐generating 
capacity). Pelvic floor muscles (PFM) strength is important to support and stabilize  bladder 
neck and urethra [15].
The researchers and patients see improvements in UI in different ways. Sufferers define 
improvement according to reduced lifestyle limitations or healing overall perception of 
bladder symptoms, especially recovery of urine leakage. In the view of the researchers, an 
improvement is a decrease in the amount of urine lost during pad tests, or any statistically 
significant decrease in the frequency of UI episodes [35].
There are some conservative therapy modalities to obtain improvement in patients with 
UI. Among these techniques, pelvic floor muscle training (PFMT), electrical stimulation 
(ES), biofeedback, magnetic stimulation (MS) and vaginal cones (VCs) are mostly used as 
a therapy method before surgical options in some situations. Training and strengthening 
the PFMs is recommended as the first‐line management for women with SUI, UUI and MUI 
[15, 23].
2. Pelvic floor muscle training
Pelvic floor muscle exercises (PFME) offers a possible reprieve from UI [36]. Therefore, PFMT 
remains a key factor in the prevention and treatment of UI [14]. This conservative therapy 
appears to have no significant side effects and help in improving symptoms. It can therefore 
be considered as the first choice of treatment for UI in women. The guideline states that pel‐
vic floor exercises have been found to be effective in the treatment of incontinence in more 
than 50% female patients [23, 37]. It is commonly recommended for the treatment of patients 
with SUI or MUI [38]. Less commonly, it can be used for UUI [39]. It has been demonstrated 
that PFME can improve the strength of the female PFMs contraction, increase intraurethral 
pressure and elevate the urethra to maintain continence [40, 41]. Through the agency of all 
these benefits, symptoms of SUI in women result in improvement. In addition, fast‐repeated 
contractions of the levator ani musculature have been demonstrated to stimulate the sacral 
reflex arch to suppress urinary urgency and frequency and improve UUI symptoms [41, 42].
PFMT for the management of UI has been described in several ancient texts of China, India, 
Greece and Rome [37, 43]. It was thought that strengthening this group of muscles would pro‐
mote health, longevity, spiritual development and sexual health. The first report of PFMT in 
modern medicine dates back to 1936, when a paper by Margaret Morris described tensing and 
relaxing of the PFMs as a preventative and treatment option for urinary and faecal inconti‐
nence [37]. Subsequently, PFMT was introduced to the British physiotherapy profession. 
However, PFMT was popularised by Arnold Kegel for the management of UI in 1948 and has 
since remained as a first‐line conservative measure [44–46]. In his paper “Progressive resistance 
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exercise in the functional restoration of the perineal muscles”, he reported the successful treat‐
ment in patients with SUI [47], and the term Kegel exercise, as a common misnomer for pelvic 
floor exercises, came into existence [37]. As mentioned above, PFMT commonly recommended 
and used for the treatment for SUI or MUI especially with SUI symptoms [44, 48, 49] and pelvic 
organ prolapse (POP) [50], as the first choice of treatment for SUI/MUI [38]. Less commonly, it 
is used for the treatment of UUI [32, 39, 48, 49].
PFMT is mostly aimed to improve the function of the PFM in terms of strength which is the 
maximum force generated by a muscle in a single contraction, endurance which is the ability 
to perform repetitive contractions or to sustain a single contraction over time and coordina‐
tion that is muscular activity prior to effort and on exertion, or any combinations of these, thus 
providing thereby maximum support to the pelvic organs, especially the bladder neck and 
the proximal urethra, before and during an increase in intra‐abdominal pressure, to prevent 
urine leakage [39]. PFM strength training results in an improved support to the bladder neck 
and proximal urethra, which have been observed to be poorly supported in some patients 
with UI. This is achieved by elevating the position of the levator ani muscle through muscle 
hypertrophy and increased muscle stiffness [39, 51].
There are 12 striated muscles arranged in three layers in the pelvic floor. These three layers 
consist of the endopelvic fascia, the levator ani muscles and the perineal membrane, respec‐
tively. The endopelvic fascia is the connective tissue floor of the pelvis, extending between the 
viscera to the pelvic walls. It is considered as first layer of pelvic floor. The levator ani muscles 
and their fascia are considered as second layer which is also referring as the pelvic diagram. It 
serves as horizontal sheet with anterior hiatus in the midline. The urethra, the vagina and the 
rectum pass through within this hiatus. If this layer is disrupted during parturition, there will 
have a consequent effect on all the three structures. The last layer is the perineal membrane 
(or in other words urogenital diaphragm) and lies at the hymeneal ring. In females it does not 
complete due to the position of the vagina. Thus, this membrane provides some weak support 
for the urethra. Lying under the perineal membrane are the ischiocavernosus, bulbocaverno‐
sus and superficial transverse perineal muscles [52].
The PFMs consist of muscle fibres, of which 70% are slow‐twitch type 1, that is, fatigue‐
resistant fibres maintaining static tone and 30% are fast‐twitch type 2 that is fatigue‐prone 
fibres being capable of active contraction. In some situations like aging, inactivity and nerve 
innervation damage, there might be a decrease in the proportion of the fast‐twitch fibres [53]. 
Doing exercise can increase PFM strength, durability and responsiveness [47, 54].
In order to prevent UI, PFMT works in several ways. In females, the bladder neck and urethra 
are supported by the PFMs. Just before intra‐abdominal pressure begins to increase, PFMs 
is activated and this activation is maintained during increased intra‐abdominal pressure. 
Contraction of PFMs pressures the urethra to the pubic symphysis. Consequently, the ure‐
thral resistance increases and this increased resistance prevents involuntary loss of urine. It is 
demonstrated that urethral and bladder neck descent and leakage of urine can be prevented 
by a well‐timed contraction when intra‐abdominal pressure increases. The repetitive exercises 
which are done regularly cause muscle hypertrophy, improve the urethral resistance and help 
to prevent POP [50].
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PFMs integrity appears to play an important role in the continence mechanism. Therefore, 
there is a biological rationale in improving the use of PFMT in preventing and treating UI 
in women [47]. There are two main biological reasons for using PFMT. Firstly, a voluntary 
contraction before and during a cough has been shown to effectively reduce urinary leakage 
during cough (a manoeuvre termed “The Knack”) [55]. Secondly, increase in PFMs strength 
is thought to beef up long‐lasting structural support to the pelvis by ascending the levator 
plate. This is also enhanced by hypertrophy of the muscles which increases further the stiff‐
ness of the PFMs and connective tissues [51]. Thus, perineal descent during increased intra‐
abdominal pressure could be prevented by improving the PFM strength. Improvement in the 
PFM strength may also facilitate PFMs before and during the effort, thereby reducing SUI 
in women. Given the above biological rationale, while treating SUI, the focus of any PFMT 
should be improving the timing of the contraction, strength and stiffness of the PFMs [48].
PFME, which includes repetitively selective voluntary contraction and relaxation of the spe‐
cific PFMs [27], is used to increase the strength of the PFMs and periurethral muscles. This 
in turn improves the efficiency of the supportive function by immobilising the urethra and 
improves the sphincteric function by increasing the intraurethral closure pressure during 
physical activities [51, 56]. The movement is a voluntary inward and upward contraction and 
squeeze of the pelvic floor. The basic principles of muscle training according to the American 
College of Sports Medicine are based on progressive overload, specificity and periodisation, 
which need to be incorporated into any resistance training programme in order to achieve 
maximum results [48]. As the pelvic floor is entirely composed of striated muscles, the prin‐
ciples of strength training for the striated muscle can also be applied to PFMs [37, 48]. During 
the PFMT, the purpose of progressive overload is to gradually increase the intensity of the 
exercises and the number of repetitions throughout the exercise programme. By submaximal 
loads, the speed of the repetitions should be adjusted according to the desired goal. For endur‐
ance improvement and power training or lengthened for strength, the rest periods should be 
shortened. In the end, the overall volume of training should be increased gradually [37].
Different studies have recommended different number of contractions ranging from 8 to 12 
contractions three times a day to 20 contractions four times a day and up to as many as 200 
contractions per day [37]. To obtain increased muscle strength of PFMs, it is necessary to 
apply a method, named as the progression model. This method requires doing repetition 
from 8 to 12 times with maximum contractions at moderate velocity and 1 or 2 min breaks 
between sets. Moreover, number of initial trainings which were two to three times in a week 
should be increased to four to five times per week. Additionally, as a person can achieve the 
current workload for one to two repetitions over the determined number, the initial work 
load should be increased about 2–10%. In order to increase muscle endurance, the progres‐
sion model suggests the need for light to moderate loads (40–60% of maximal load) with high 
repetitions (>15) and short rest periods (<90 s) for endurance training. In PFMT, progression 
can be achieved by changing positions from gravity‐free to antigravity or through the intro‐
duction of cones into the exercise sessions. Finally, if it is desired to obtain better outcomes 
according to progression model, velocity and coordination training (“The Knack”) should 
include the use of repetitive, voluntary PFMs contractions in response to specific situations; 
for example, prior to and during coughing, lifting an object or jumping [48]. The National 
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Institute for Health and Care Excellence (NICE) recommends PFMT comprising at least eight 
contractions three times daily for at least 3 months as the first‐line therapy for the women 
with SUI [23]. The American College of Obstetricians and Gynaecologists also recommends 
PFMT as the first‐line therapy for the women with SUI and states that PFMT is more effective 
than ES or VCs [57].
There are different recommended postures that are adopted during the prescribed exercise 
regimen. These postures include sitting, kneeling, standing, lying down and standing with 
legs astride. There are huge variations in the recommended duration of the prescribed regi‐
men starting from 1 week to 6 months, with 3 months being most frequently recommended. 
Across studies the number of contractions ranges from 8 to 12 contractions three times a day, 
to 20 contractions four times a day, to as many as 200 contractions per day [37]. NICE recom‐
mends a trial of supervised pelvic floor exercises, consisting of at least eight contractions three 
times a day for a minimum of 3 months, as the first‐line treatment for UI [37, 58]. The recom‐
mended supervised PFMT by The International Consultation on Incontinence Committee for 
women with SUI is 8–12 weeks before reassessment with a possible referral for further man‐
agement, if the patient does not improved desirably [37, 59]. The intensity of the contraction 
seems to be more important than frequency of training [60].
To obtain better outcomes from PFMT, PFMs may be activated together with the abdominal 
muscle. It is known that active contraction of the transversus abdominis (TA) muscle is associ‐
ated with co‐activation of the PFMs. However, PFMs are not raised in all women by the TA 
muscle contraction. In recent studies, it is suggested that the relationship between PFM and 
TA muscle vary between continent and incontinent women. In incontinent women with SUI, 
TA muscle contraction with the PFM being displaced less during the contraction of TA muscle 
as compared to the continent women [37].
Among the conservative treatment options, this conservative therapy appears to have no side 
effects and enables improvement in symptoms; it can therefore be considered as a first choice 
of treatment for UI in women [37].
3. Electrical stimulation
Another popular intervention used by physiotherapists to reduce UI is ES. It is one of the first‐
line conservative treatment option for female UI and widely used in the management of it. 
ES physiologically produces muscle hypertrophy, normalises the reflex activity of the lower 
urinary tract and increases circulation to muscles and the capillary system [7, 61]. It may also 
increase conscious awareness of the action of PFMs to provide an improved ability to perform 
a voluntary muscle contraction. With regard to a recent systematic review, ES does not differ 
from sham stimulation or PFME in terms of improvement in UI [62]. However, ES is a priority 
for women with difficulty in contracting the PFMs initially [7, 61].
ES is a therapeutic option for patients with UI and based on the application of electrical 
impulses to the peripheral nerves [63]. In 1963, ES of the muscles of the pelvic floor was 
first offered by Caldwell to address urinary and faecal incontinence. Since then, clinical trials 
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showed some efficacy in treating UI particularly in SUI, UUI and MUI [31, 64]. It includes the 
application of ES to the suprapubical, transvaginal, sacral and tibial nerves [64] and denoted 
as functional ES [31]. The process of sacral nerve stimulation includes implantation of a wire 
electrode in one of the sacral foramina, usually S3, which is then connected to a stimulator 
device. In most cases, it is useful for refractory UI and idiopathic urinary retention [65, 66]. ES 
of the tibial nerve is a peripheral non‐implantable method, which can be applied percutane‐
ously with a needle or transcutaneously with a stick‐on electrocardiograph‐type electrode [31, 
65]. In this, S2‐S4 crossroads of the sacral nerve plexus delivers neuromodulation to pelvic 
floor through the less invasive route of the posterior tibial nerve. There are projections in this 
area to the sacral nerve plexus. A feedback loop is generated, modulating bladder innerva‐
tions [31, 67]. The main of suprapubical ES is to make a direct stimulation of S3 nerve roots, in 
order to inhibit the detrusor activity, equivalently to the sacral ES, but is less invasive [31, 68].
ES is generally directed with a removable device through vaginal or anal stimulation [69]. The 
electrodes can be implantable or non‐implantable, and the ES can be of long or short dura‐
tion [31]. The electrodes are placed in the vaginal or rectal canals in such a way as to acquire 
direct contact with a remarkable amount of afferent nerve fibres of the pudendal nerve [70]. It 
is necessary to partially or totally innervate the pudendal nerve so that nerve stimulation can 
occur [70, 71]. The advantage of this therapy is that it does not ask for voluntary patient effort; 
however, the passive muscle contractions are generally weaker than the voluntary ones [63].
The mechanism of action of this modality relies on the ES to induce hypertrophy of skeletal 
PFM [25, 72], which cannot be achieved by voluntary muscle contractions via reflex contrac‐
tions, while activating the detrusor inhibitory reflex arc [25, 72]. The important outcomes of 
electrical stimulation are the reorganisation of spinal reflex and regulation of cortical activity, 
which are related to the mechanism of action of this therapy [73]. The mechanism of action of 
ES is to promote bladder relaxation by inhibiting the parasympathetic motor neurons. Other 
studies reported that transvaginal ES causes contractions of the pelvic floor, increasing the 
number of muscle fibres with rapid contraction, which are responsible for continence in con‐
ditions of stress [31, 65].
The aim of ES in the treatment of patients with SUI appears to improve the function of the 
PFMs [74] by stimulating its contraction, with the goal of achieving a training effect to ensure 
that the pelvic floor will provide adequate support with the advancement in PFM strength to 
prevent urine loss during an increase in intra‐abdominal pressure [75]. While for women with 
UUI, the intention seems to be to inhibit detrusor overactivity [74].
The principle of ES for the treatment of SUI based on the delivery of electrical impulses to 
directly trigger reflex contraction of the PFMs through the pudendal nerve and by activating 
three concomitant central actions. These concomitant actions are activation of hypogastric 
inhibitory fibres to the bladder, central inhibition of pelvic outflow to the bladder and central 
inhibition of the ascending afferent pathway from the bladder. Voluntary pelvic floor muscle 
contraction does not lead to the activation of this reflex pathway [72, 76].
ES can evoke direct contractions of the PFM in patients with detrusor overactivity or symp‐
toms of urgency and UUI. The contractions stimulate afferent fibres of the pudendal nerve 
Physiotherapy in Women with Urinary Incontinence
http://dx.doi.org/10.5772/64611
59
going to the sacral spinal cord [2], and this stimulation induces a reflex contraction of the 
striated paraurethral and periurethral muscles, accompanied by a simultaneous reflex inhibi‐
tion of the detrusor muscle [69, 72, 76, 77]. This response leads to a reflexive decrease in the 
feeling or sensation of urgency and inhibits parasympathetic activity at the level of the sacral 
micturition centre in the sacral cord that eventually reduces involuntary detrusor contractions 
and reflexively activates the striated periurethral musculature [2]. Peripheral innervation of 
the PFMs must at least be partly intact to gain a therapeutic effect of pelvic floor stimulation 
in women with detrusor overactivity [78].
There are major inconsistencies that exist between several electrostimulation protocols, partly 
due to a lack of understanding of the physiological principles of electrostimulation and the 
way it could contribute to recuperation from SUI in women. Different forms of electrostimula‐
tion are distinguished in physical therapy, brief maximal stimulation, which is usually per‐
formed at a physical therapy centre and prolonged, low‐intensity electrostimulation, which 
can also be performed at home. The potential side effects of electrostimulation include pain 
and tissue damage; electrostimulation is contra‐indicated if patient is using a pacemaker or in 
case of pregnancy [61]. Stimulation parameters have been defined on the basis of neurophysi‐
ological and clinical studies (Figure 3) [72, 79].
3.1. PFME and electrical stimulation
Patients with very weak PFMs often have difficulty identifying and activating their muscles 
to improve symptoms of SUI. In this situation, ES can be useful to activate PFMs. To improve 
the efficacy of PFMT, it is combined with ES. Hence, combination of these might facilitate 
training by helping patients to better identify and strengthen their muscles, leading to better 
treatment outcomes [34]. The sense of contracting the PFMs is a useful reminder to the patient 
of the sensation that should be perceived, and they are encouraged to actively try to contract 
the PFM during ES [33, 79].
Figure 3. Stimulation parameters of electrical stimulation.
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It may be that electrical stimulation is particularly appropriate for patients who are initially 
unable to contract their PFM, but once active contraction is achieved, PFME may be more 
effective [80, 81].
In most physiotherapy practices, electrical stimulation is used for partially paralysed muscles 
and to stimulate the activity when the patients are unable to contract it voluntarily. Most 
physiotherapists prefer stop using ES and continue with regular muscle training when the 
patient can contract voluntarily [82].
In general, there are two main mechanisms by which ES is believed to work. One of these ES 
in the form of neurostimulation aims to stimulate motor efferent fibres of the pudendal nerve, 
which elicits a direct response from the effector organ, for instance, a contraction of the PFMs 
[70, 83, 84]. Other mechanism of these, ES in the form of neuromodulation aims to remodel 
reflex loops, for instance, the detrusor inhibition reflex by stimulating afferent nerve fibres of 
the pudendal nerve that influence these reflex loops via the spinal cord [70, 85].
4. Biofeedback
One of the recent definitions of biofeedback is giving an indication on bodily processes using 
an external sensor within a group of experimental procedures, mostly in order to readjust the 
measured quality [82]. Another definition is coexisting, simultaneous or terminal biological 
feedback of biological signals allowing a person to determine and modify a bodily function of 
which they are usually unacquainted [86, 87].
Assisting patients for the determination and also their exercise the PFM properly is accepted 
as the main objective of biofeedback [34]. Although it is not a therapy in itself, it is possible to 
be applied in the treatment of patients with SUI for several reasons. Firstly, it provides them 
an indication of their PFM activity at rest, in contraction and relaxation modes; secondly, it 
gives not only the strength of individual contractions of the PFMs but also the strength of the 
contracting PFMs or the way in which certain muscles contract and the direction of contrac‐
tion. Since biofeedback gives information related with the learning and controlling the func‐
tions of the activity of striated muscles through varied audio‐visual techniques, it can also be 
used to educate a certain patient suffering SUI, about the selective contraction of their PFMs. 
Introducing a sensor or electrode into the vagina or rectum is the most common method 
to provide biofeedback. By this way, the vaginal or rectal pressure or the electromyogram 
(EMG) signal of the sphincter muscle is recorded. The visual or acoustic information about the 
pressures measured and/or the EMG signals are sent to the patients, thus enabling them to see 
the magnitude of the force being generated by the PFMs and to know if this force has reached 
its maximum level. The technique can also be used to visualise progress, which obviously 
motivates patients to keep exercising (biofeedback device is shown in Figure 4). Biofeedback 
is not a therapy to be applied solely; however, it is possible that a combination of biofeedback 
and PFMT is beneficial for decreasing the reluctant leakage of urine in SUI suffering patients. 
The efficacy and professional knowledge of a physical therapist plays a significant role on the 
effective results of biofeedback usage [61].
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Even though biofeedback technology is accepted as a proven technique assuring proper muscle 
control, it needs specific equipment as well as professional expertise, which results in longer 
time period and higher financial cost [34]. The contribution of the field of psychology has been 
required for the development of the biofeedback equipment; hence, varied forms of stress are 
needed to be measured through sweating, heart rate and blood pressure. Using vaginal palpa‐
tion and clinical observation during the instruction of accurate contraction was indispensable 
for Kegel's training protocol [47]. During Kegel's exercise, as biofeedback, a combination of 
PFMT and vaginal squeeze pressure measurement was used. Nowadays, in clinical practice, 
wide ranges of biofeedback apparatus are in use [82]. Biofeedback devices vary considerably. 
They can be inserted into the rectum or vagina or placed on the perineum. Many of the bio‐
feedback devices addressed in this review are either air‐ or water‐filled balloons inserted into 
the rectum or vagina to measure pressure. Vaginal, anal and intra‐abdominal pressure can be 
measured regulated by the balloon catheters’ quantity and induction. The other main group of 
biofeedback devices measures electrical activity (i.e. electromyography) via surface metal elec‐
trodes on vaginal or anal probes. Displaying movement, such as moving bladder neck upwards, 
is another claim of biofeedback, which can be provided by ultrasound real time images [87].
A number of studies have tried to figure out which method is more beneficial to teach pel‐
vic floor muscle control: biofeedback training or digital palpation with verbal feedback. 
However, they are not consistent, and there is need to studies coming up with a clear benefit 
biofeedback to a PFMT program [34, 87]. Biofeedback could be implemented for patients 
Figure 4. Biofeedback device.
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who cannot identify their muscles well by other methods. Additionally, it is suggested that 
behavioural methods can be used more widely particularly in settings where biofeedback is 
not accessible [34].
Biofeedback‐assisted exercises present the advantage of additional acoustic and visual guid‐
ance for the patient, which makes it easier for them to learn and perform the exercises appro‐
priately [88, 89]. Another advantage of biofeedback is to help the women who have difficulty 
in isolating their PFM during training. Furthermore, patients who can identify the PFM often 
find that the required daily exercise routine is burdensome. Most of the patients fail to comply 
with the PFMT for a long‐term [89, 90]. ES is a non‐invasive, passive treatment that produces 
a muscle contraction [89, 91]. PFM contraction by indirect nerve stimulation and polysynaptic 
reflex responses is caused by transvaginal electrical stimulation (TES) [89, 90, 92]. As long as 
performed accurately, PFMT results more effective than ES because of the indirect stimula‐
tion and reflexive contraction. Biofeedback‐assisted PFMT and TES have been used together 
to improve therapeutic effect [89].
4.1. PFME along with biofeedback
In the field of urology or urogynaecological, the term “biofeedback” is often used to classify 
a method different from PFMT. Biofeedback is helpful for training and evaluating response 
from a single PFMs activity. In the area of PFMT, with both vaginal and anal surface EMG, 
urethral and vaginal squeeze pressure measurements have been utilised with the purpose 
of making the patients to know better their muscle functions and to enhance and motivate 
patients’ effort through training [82, 93]. PFME are possible to be supported by biofeedback, 
since it gives relative information on unconscious physiological processes. Provided informa‐
tion establishes the primary support for active self‐control processes under observation [69].
In SUI treatment, biofeedback could be used in combination with PFMT to demonstrate PFM 
activity at rest, on activity and in relaxation period. In addition, it represents the ability of a 
person (by electromyogram) or overall (pressure measurement) PFM contraction. However, 
combination of PFME with biofeedback is not more effective than PFMT which is done solo 
[75, 94, 95]. Although each treatment modalities are useful by itself, it is probable that bio‐
feedback added value in SUI patients suffering unawareness and/or control of the pelvic 
floor, quick improvement from the beginning phase and motivate the patients for the exer‐
cise [60, 75].
The exact contraction may be verified by using biofeedback or manual palpation. In women, 
biofeedback is applied by using small electrodes which are placed around the anus or by 
using an internal vaginal electrode. Biofeedback allows women to see their muscle output 
during an exercise instantly. However, information available in the literature suggests that 
PFME with biofeedback is not as effective as PFME applied alone. On the other hand, combin‐
ing PFME with biofeedback can be clinically beneficial and acceptable treatment procedure 
for certain groups of woman. A practical strategy may be to begin with PFME with biofeed‐
back for those who might have difficulty in understanding how to contract or are unable to 
contract the PFM. Biofeedback can also be used to teach the correct form of PFME [7].
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5. Vaginal cones
PFMT is the main approach of conservative (non‐surgical) treatment in SUI. It is based on 
strength training or identification or both for the PFM to overcome weakness by increasing 
the support of urethra and bladder, and improving sphincteric action of muscles around the 
urethra [96].
On the other hand, this muscles group seems rather difficult to be determined and controlled 
by women. Moreover, these muscles are below par to the training completion; hence, it will 
probably require other intervention modalities [25]. In addition, incorrect PFMs contractions 
can make the incontinence worse [97]. While considering these reasons, weighted VCs were 
developed as a method of strengthening and testing the function of the PFM [98].
Plevnik introduced the usage of VCs in 1985 [98]. His aim was to strengthen PFMs with the 
VCs by inserting them in the vagina higher to the pelvic floor musculature [63]. Theoretically, 
when a cone is placed in the vagina, the PFMs need to be contracted to prevent the cone slip‐
ping out [96]. The sensation of losing the cones from the vagina provides a strong sensory 
feedback and prompts a PFM contraction in order to retain the cone [74]. In order to keep the 
cone inside the vagina, these muscles are needed to be contracted. Same sized but different 
weighted set of VCs are given to the patient and she is asked to insert a cone of increasingly 
heavier weight until she can hold the earlier lighter one [61, 63]. Developing muscular over‐
load is provided by the cones. During the exercise process, the patient inserts the selected 
cone intravaginally, above the level of the levatores muscle plate, using a standardised proce‐
dure, and tries to hold the cone in place for up to 15 min by contracting her PFMs [61, 99]. If a 
positive result is obtained twice in a row, the training can be continued with the subsequent 
heavier cone. A training based on this principle is believed to strengthen the PFMs under 
simultaneous proprioceptive feedback [61].
There are some perceived advantages of the cones over traditional methods of training the 
PFMs [96, 100–102] and these are demonstrated in Table 2.
The probability of maintaining sensory‐motor biofeedback brings about the certain advan‐
tages of strengthening the PFMs by using VCs [103]. This sensory‐motor biofeedback can pos‐
sibly maximise the neural gains as the greatest activation and synchronisation of the motor 
units [104]. And hence, the vaginal cone usage would support an accelerated improvement in 
muscle strength through neural mechanisms, followed by muscle hypertrophy in response to 
resistance training with progression of the cone weight [104, 105].
Although working out with cones has been criticised as not being suitable for all women 
especially with a narrow and scarred vagina or individual admissibility and weight of the 
cone may not represent the strength of PFM, weighted VCs has been shown to increase the 
strength of the PFM and has been found to have similar efficacy in comparison with PFME 
and ES. However, it enjoys the benefit of requiring less time to train for its application with 
need of only one or two consultations, being able to be used without supervision, providing 
a form of biofeedback and helping muscle synchronisation with increases in abdominal pres‐
sure [96, 104]
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6. Mechanical devices
Vaginal support prostheses have been in use for a long time. Although these devices are primar‐
ily used for POP, there has been some interest in developing those specific for SUI. Some poten‐
tial advantages of these vaginal support devices include their potential to be applicable to the 
majority of the incontinent patients, mild side effects and non‐requirement of any specific testing 
(e.g. urodynamic testing). Conversely, these devices do not definitively treat the problem, and if 
the problem worsens, the patient health may require a surgical intervention. Furthermore, these 
devices have no correction effect on intrinsic sphincter deficiency in reality, and may not help 
patients with hypermobility. There is a recent Cochrane review looked at seven trials involving 
over 700 women [106]. Three are small trials comparing mechanical devices (intravaginal such 
as pessary, sponge or tampon‐like device) with no treatment suggested that use of a mechanical 
device might be better than no treatment; however, results were not conclusive. Urethral plugs 
passively occlude and/or coapt the urethra, but require removal for voiding. Overall results of 
the studies of Staskin and associates were generally favourable [107]. Although urethral inserts 
can work for most of the women with pure SUI, the shortcoming that these devices must be 
removed and reinserted with each void is not accepted by most of them [25].
7. Magnetic stimulation
Magnetic stimulation is a novel approach, coming up in recent years. The United States Food 
and Drug Administration approved MS as a conservative treatment for UI in 1998 [29, 108]. 
Ever since, to evaluate its efficacy in UI, more than 50 clinical experiments have been con‐
ducted worldwide [29, 109]. However, the multitude of information was overwhelming. 
According to clinicians, there is a need to compile these informations so that evidence‐based 
decisions could be taken [29].
1 Advantages of the cones
2 The exercise is individualised for each woman
3 Less time is needed to teach women to use the cones than to teach PFMT
4 It does not take much time to insert and remove cones
5 The use of VCs can be self‐taught, and they can be used without supervision and vaginal 
examination
6 The graded increases in cone weight represent improvement in muscle strength and motivates 
women to continue
7 Usually only one consultation is needed
8 Cones can be used in self‐instruction of conventional PFMT
The cones provide a form of biofeedback as the sensation of one slipping out induces a PFM 
contraction which may both strengthen muscles and help to synchronize muscle contraction with 
increases in abdominal pressure
Table 2. Advantages of the weighted vaginal cones.
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To use of MS there must be special chair. An electric current is passed around a metal coil, 
generating an electromagnetic field. When the person exposed to this field, electric current is 
generated in tissues. Thus, PFMs is stimulated by the MS in a similar way to ES. In this case, 
the patients are required neither to undress nor to insert electrodes, as the electromagnetic 
fields spread easily through tissues causing ES [110, 111]. It has an armed treatment chair for 
the patient to sit comfortably and a compact control unit (Figure 5). It contains a generator, 
control buttons, a monitoring screen and modem, and is equipped with automatic payment 
system for treatment sessions. The stimulation coil is situated underneath the treatment chair 
to ensure direct focus on PFMs [108, 111].
It has not been established that the optimal frequency and pulse duration in MS yet. However, 
using more than 50 Hz has been reported as necessary to achieve an adequate PFMs contrac‐
tion for treatment of SUI [109], and 38–40 Hz and less than 10–20 Hz for UUI [29, 112, 113].
Conservative therapy should be considered prior to the initiation of medical or surgical treatment 
of UI. Because of its demonstrated efficacy, low risk and apparent low cost, published clinical 
guidelines recommend that conservative management. Pelvic floor muscle training is recom‐
mended as first‐line conservative management for treating urinary incontinence. Additional 
physical therapies, such as electrical stimulation, biofeedback or magnetic stimulation can be 
considered in women who cannot actively contract their pelvic floor muscles, in order to aid 
motivation and adherence to therapy. Physiotherapists need to understand the nature of the 
urinary incontinence, the influence prognostic factors and the principal of therapy modalities.
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Figure 5. Equipment of magnetic stimulation.
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